Dennis Coffey MD
Pediatric Critical Care Medicine
Division Chief, Pediatric Critical Care Medicine - Director, Pediatric Intensive Care Unit
Join to View Full Profile
1000 Montauk HighwayWest Islip, NY 11795
Dr. Coffey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dennis Coffey, MD, is a pediatric specialist based in West Islip, NY, with a subspecialty in Pediatric Critical Care Medicine. He completed his pediatrics residency at Children's National Hospital from 1993 to 1996, followed by a fellowship in Pediatric Critical Care Medicine at New York Presbyterian Hospital (Cornell Campus) from 1996 to 1999. Dr. Coffey graduated from Rutgers Robert Wood Johnson Medical School in 1993, after earning an AB in Molecular Biology from Princeton University in 1989. His research publications have been widely cited, including studies on multisystem inflammatory syndrome in children and various works involving histone deacetylase inhibitors.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Critical Care Medicine, 1996 - 1999
Children's National HospitalResidency, Pediatrics, 1993 - 1996
Rutgers Robert Wood Johnson Medical SchoolClass of 1993
Princeton UniversityAB, Molecular Biology, 1985 - 1989
Certifications & Licensure
NJ State Medical License 2005 - 2027
NY State Medical License 1996 - 2027
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Critical Care Medicine
Publications & Presentations
PubMed
- 75 citationsIncidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2.Amanda B. Payne, Zunera Gilani, Shana Godfred-Cato, Ermias D. Belay, Leora R. Feldstein
JAMA Network Open. 2021-06-01 - 52 citationsHistone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro.Martha C. Kutko, Richard D. Glick, Lisa M. Butler, Dennis C. Coffey, Richard A. Rifkind
Clinical Cancer Research. 2003-11-15 - 130 citationsThe histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid.Dennis C. Coffey, Martha C. Kutko, Richard D. Glick, Lisa M. Butler, Glenn Heller
Cancer Research. 2001-05-01
Press Mentions
Severe Respiratory Illness Cases Possibly Tied to Vaping Rises to 152 in 16 StatesJune 8th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
